Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc. T.DN

Alternate Symbol(s):  DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


TSX:DN - Post by User

Bullboard Posts
Post by johnaboon May 30, 2019 5:22pm
89 Views
Post# 29786715

Financials are out! $5.6M Revenue $11.11 M Net Profit

Financials are out! $5.6M Revenue $11.11 M Net Profit
Record operating revenues of $5.63 million for the first quarter of 2019, up 1,595%, from $332,107 for the same quarter last year. Sequential net revenues increased 7% from $5,270,217 for the three-month period ending December 31, 2018. Sequentially the cost of sales of cannabis products improved by 5% to $3.82 million for Q1, 2019 from $4.02 million for the fourth quarter of 2018. Record gross profit of $4.22 million for the first quarter, 2019, up 1,983%, from $202,695 for the same quarter last year. Sequential gross profit increased 26% from the three-month period ending December 31, 2018 Gross profit margin was 75% for Q1, 2019 Net income for Q1, 2019 was $11.11 million or $0.13 per share versus a net loss of ($1.92) million or ($0.02) for the three-month period ending March 31, 2018. Management would highlight the one-time gain on the disposal of the Company's investment in the Delta West Limited Partnership (the "Delta West LP") as contributing a significant non-cash gain during the period. Without the one-time gain, Delta 9 recorded a loss from operations of ($946,180) or ($0.01) for Q1, 2019 versus a loss of $1,923,263 or ($0.02) for the same period last year. The Company reported a strong financial position, with working capital of $18.83 million and total assets of $65.35 million.
Bullboard Posts